UBS downgraded PharMerica (NYSE: PMC) from Buy to Neutral with a price target of $22.00 (from $40.00), saying they see ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE